Journal article
Successful treatment of Paecilomyces lilacinus endophthalmitis with voriconazole.
- Garbino J Division of Infectious Diseases, University of Geneva Hospitals, Switzerland. jorge.garbino@hcuge.ch
- Ondrusova A
- Baglivo E
- Lew D
- Bouchuiguir-Wafa K
- Rohner P
- Baligvo E
- 2002-10-11
Published in:
- Scandinavian journal of infectious diseases. - 2002
Adolescent
Adult
Aged
Antifungal Agents
Endophthalmitis
Female
Humans
Male
Middle Aged
Mycoses
Paecilomyces
Pyrimidines
Triazoles
Voriconazole
English
Paecilomyces lilacinus is a rare cause of endophthalmitis and there are few reports of it in the literature. Herein we report a patient with P. lilacinus endophthalmitis who was treated with the new triazole, voriconazole, for 4 months, with a good clinical evolution. This treatment appears to be a valuable new therapeutic option but requires further clinical confirmation.
- Language
-
- English
- Open access status
- closed
- Identifiers
-
- DOI 10.1080/00365540210147642
- PMID 12374371
- Persistent URL
- https://sonar.ch/global/documents/175182
Statistics
Document views: 26
File downloads: